<code id='096AB2D15B'></code><style id='096AB2D15B'></style>
    • <acronym id='096AB2D15B'></acronym>
      <center id='096AB2D15B'><center id='096AB2D15B'><tfoot id='096AB2D15B'></tfoot></center><abbr id='096AB2D15B'><dir id='096AB2D15B'><tfoot id='096AB2D15B'></tfoot><noframes id='096AB2D15B'>

    • <optgroup id='096AB2D15B'><strike id='096AB2D15B'><sup id='096AB2D15B'></sup></strike><code id='096AB2D15B'></code></optgroup>
        1. <b id='096AB2D15B'><label id='096AB2D15B'><select id='096AB2D15B'><dt id='096AB2D15B'><span id='096AB2D15B'></span></dt></select></label></b><u id='096AB2D15B'></u>
          <i id='096AB2D15B'><strike id='096AB2D15B'><tt id='096AB2D15B'><pre id='096AB2D15B'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:44

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

          How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

          advertisement

          STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

          Featured speakers:

          • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
          • Ramita Tandon, chief clinical trials officer, Walgreens
          • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
          • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
          • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

          Sponsored By

          OneStudyTeam

           

          Wikipedia

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Intercept Pharmaceuticals sells itself for less than $1 billion
          Intercept Pharmaceuticals sells itself for less than $1 billion

          AdobeInterceptPharmaceuticals,afirmwhosetreatmentforaprevalentliverdiseaseoncemadeitthehotteststocki

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          FDA panel endorses Alnylam’s heart drug — after picking it apart

          KristofferTripplaar/SipaUSA/APAgroupofadviserstotheFoodandDrugAdministrationvotedinfavorofAlnylamPha